Current Report Filing (8-k)
February 15 2017 - 4:37PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
February 15, 2017
Date of Report (Date of Earliest Event Reported)
The Chemours Company
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-36794
|
|
46-4845564
|
|
(State or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer
|
|
Of Incorporation)
|
|
File Number)
|
|
Identification No.)
|
1007 Market Street
Wilmington, Delaware, 19899
(Address of principal executive offices)
Registrant’s telephone number, including area code: (302) 773-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02
Results of Operations and Financial Condition.
On February 15, 2017, The Chemours Company issued a press release regarding its fourth quarter and full year 2016 financial results. A copy of the press release is furnished hereto as Exhibit 99.1.
The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it will not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
99.1
Press release dated February 15, 2017.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
THE CHEMOURS COMPANY
|
|
|
|
By:
|
|
/s/ Mark E. Newman
|
|
|
|
Mark E. Newman
|
|
|
|
Senior Vice President and
|
|
|
|
Chief Financial Officer
|
|
|
|
Date:
|
|
February 15, 2017
|
Chemours (NYSE:CC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chemours (NYSE:CC)
Historical Stock Chart
From Apr 2023 to Apr 2024
